Overview

A Randomized, Open Label, Single Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Exforge® and G-0081 in Healthy Male Volunteers

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
Study Design : randomized, open label, single-dose, 2-way cross-over design Phase : Phase I
Phase:
Phase 1
Details
Lead Sponsor:
Dong-A Pharmaceutical Co., Ltd.
Treatments:
Amlodipine
Amlodipine, Valsartan Drug Combination